Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr 23:3:148.
doi: 10.3389/fmicb.2012.00148. eCollection 2012.

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

Affiliations

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

Ignasi Roca et al. Front Microbiol. .

Abstract

During the past few decades Acinetobacter baumannii has evolved from being a commensal dweller of health-care facilities to constitute one of the most annoying pathogens responsible for hospitalary outbreaks and it is currently considered one of the most important nosocomial pathogens. In a prevalence study of infections in intensive care units conducted among 75 countries of the five continents, this microorganism was found to be the fifth most common pathogen. Two main features contribute to the success of A. baumannii: (i) A. baumannii exhibits an outstanding ability to accumulate a great variety of resistance mechanisms acquired by different mechanisms, either mutations or acquisition of genetic elements such as plasmids, integrons, transposons, or resistant islands, making this microorganism multi- or pan-drug-resistant and (ii) The ability to survive in the environment during prolonged periods of time which, combined with its innate resistance to desiccation and disinfectants, makes A. baumannii almost impossible to eradicate from the clinical setting. In addition, its ability to produce biofilm greatly contributes to both persistence and resistance. In this review, the pathogenesis of the infections caused by this microorganism as well as the molecular bases of antibacterial resistance and clinical aspects such as treatment and potential future therapeutic strategies are discussed in depth.

Keywords: Acinetobacter baumannii; antimicrobial peptides; antimicrobial resistance; biofilm; pathogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scanning electron microscopy (SEM) (A–C). Transmission electron microscopy (TEM) (D–F) of an A. baumannii biofilm-forming strain in liquid medium. Black arrow specifies appendage structures (pili or fimbriae), and white arrow the thick exopolysaccharide layer. All electron microscopy images are derived from the work by Espinal et al. (unpublished data)
Figure 2
Figure 2
Schematic overview of the conserved AbaR structure found in A. baumannii isolates belonging to the European clone I lineage and that of AbaR22, isolated from strain MDR-ZJ06 belonging to the European clone II lineage (Zhou et al., 2011).

References

    1. Acosta J., Merino M., Viedma E., Poza M., Sanz F., Otero J. R., Chaves F., Bou G. (2011). Multidrug-resistant Acinetobacter baumannii Harboring OXA-24 carbapenemase, Spain. Emerging Infect. Dis. 17, 1064–106710.3201/eid1706.091866 - DOI - PMC - PubMed
    1. Adams M. D., Chan E. R., Molyneaux N. D., Bonomo R. A. (2010). Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 3569–357710.1128/AAC.00057-10 - DOI - PMC - PubMed
    1. Adams M. D., Goglin K., Molyneaux N., Hujer K. M., Lavender H., Jamison J. J., MacDonald I. J., Martin K. M., Russo T., Campagnari A. A., Hujer A. M., Bonomo R. A., Gill S. R. (2008). Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J. Bacteriol. 190, 8053–806410.1128/JB.01011-08 - DOI - PMC - PubMed
    1. Adams M. D., Nickel G. C., Bajaksouzian S., Lavender H., Murthy A. R., Jacobs M. R., Bonomo R. A. (2009). Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53, 3628–363410.1128/AAC.00284-09 - DOI - PMC - PubMed
    1. Adams-Haduch J. M., Onuoha E. O., Bogdanovich T., Tian G. B., Marschall J., Urban C. M., Spellberg B. J., Rhee D., Halstead D. C., Pasculle A. W., Doi Y. (2011). Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in the United States. J. Clin. Microbiol. 49, 3849–385410.1128/JCM.00619-11 - DOI - PMC - PubMed